2016
DOI: 10.1038/ncomms13306
|View full text |Cite
|
Sign up to set email alerts
|

Bioengineering of injectable encapsulated aggregates of pluripotent stem cells for therapy of myocardial infarction

Abstract: It is difficult to achieve minimally invasive injectable cell delivery while maintaining high cell retention and animal survival for in vivo stem cell therapy of myocardial infarction. Here we show that pluripotent stem cell aggregates pre-differentiated into the early cardiac lineage and encapsulated in a biocompatible and biodegradable micromatrix, are suitable for injectable delivery. This method significantly improves the survival of the injected cells by more than six-fold compared with the conventional p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
119
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 101 publications
(122 citation statements)
references
References 59 publications
(116 reference statements)
2
119
0
Order By: Relevance
“…To address this issue in other systems, a variety of natural and synthetic 3D culture systems have been developed [55,56,57,58,59]. 3D hydrogels have also been recently used to study biophysical regulation of encapsulated NSCs.…”
Section: Recent Advanced Materials To Probe and Control Nsc Mechanotrmentioning
confidence: 99%
“…To address this issue in other systems, a variety of natural and synthetic 3D culture systems have been developed [55,56,57,58,59]. 3D hydrogels have also been recently used to study biophysical regulation of encapsulated NSCs.…”
Section: Recent Advanced Materials To Probe and Control Nsc Mechanotrmentioning
confidence: 99%
“…We took a bioinspired procedure mimicking that used by nature (Fig. 1) to prepare totipotent-pluripotent stem cells for implantation in the uterus, to address this grand challenge using biomaterials systems with the bioinspired spatial and temporal complexities 29 . As shown in Fig.…”
Section: Cardiac Regeneration Using Microscale Biomaterials Systems Wmentioning
confidence: 99%
“…5C), minimizes inflammatory responses to the injected cells (Fig. 5D), and eliminates the notorious issue of teratoma formation associated with directly injecting pluripotent stem cells 29 . As a result, it significantly reduces fibrosis (Fig.…”
Section: Cardiac Regeneration Using Microscale Biomaterials Systems Wmentioning
confidence: 99%
“…[5, 6] It has shown great promise for treating various diseases including diabetes, hemophilia, cancer, liver and renal failure, as well as cardiovascular diseases. [5–7] Cryopreservation of microencapsulated cells make it possible for their wide distribution to end users so that they are readily available when needed for transplantation. [2, 3, 5, 8] It also offers a powerful tool for the integration of cell expansion and cryopreservation.…”
Section: Introductionmentioning
confidence: 99%
“…[32, 33, 35, 36] For example, core-shell structured encapsulation has been reported to better support 3D culture (providing minimized spontaneous differentiation of stem cells encapsulated in the core [4, 32, 34] ) and transplantation. [33, 37] In addition, the use of the large microcapsules may allow for rapidly processing a large volume (tens to hundreds of milliliters) of cell suspensions (which is needed for cytotherapy or cell transplantation [38] ). However, vitreous cryopreservation of cells encapsulated in large-volume microcapsules (> 500 ÎŒm in diameter) with a core-shell structure has not been done.…”
Section: Introductionmentioning
confidence: 99%